Elsevier

The Lancet

Volume 353, Issue 9159, 3 April 1999, Pages 1112-1113
The Lancet

Commentary
Breast cancer: delays, dilemmas, and delusions

https://doi.org/10.1016/S0140-6736(99)00082-3Get rights and content

References (5)

There are more references available in the full text version of this article.

Cited by (63)

  • Can we make a portrait of women with inoperable locally advanced breast cancer?

    2017, Breast
    Citation Excerpt :

    Delays caused by doctors, system barriers and patients play a major role [14]. Doctor delay defines the time period from the first medical visit to the clinical diagnosis or suspect [15]. Such delay has been mainly associated with younger age and presenting with a breast symptom other than a lump [16].

  • Increasing time delay from presentation until surgical referral for hepatobiliary malignancies

    2010, HPB
    Citation Excerpt :

    Furthermore there is no consensus on what constitutes a significant TD for cancer patients, although some expert reviews have suggested that a time between presentation and referral for definitive treatment of >30 days is unreasonable and therefore should be defined as constituting a delay in treatment.2 Delayed treatment of many non-HB malignancies is associated with negative effects on survival and disease progression.3–9 Treatment delay in hepatocellular carcinoma (HCC) of >3 months has been associated with tumour progression and decreased survival rates.10

View all citing articles on Scopus
View full text